Related references
Note: Only part of the references are listed.Hepatocellular carcinoma (HCC) survival by etiology: A SEER-Medicare database analysis.
Gagandeep Brar et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Immunologic Features of Patients With Advanced Hepatocellular Carcinoma Before and During Sorafenib or Anti-programmed Death-1/Programmed Death-L1 Treatment
Zuzana Macek Jilkova et al.
CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY (2019)
Demethylation-Induced Overexpression of Shc3 Drives c-Raf-Independent Activation of MEK/ERK in HCC
Yun Liu et al.
CANCER RESEARCH (2018)
hPCL3s Promotes Hepatocellular Carcinoma Metastasis by Activating β-Catenin Signaling
Zhen Cai et al.
CANCER RESEARCH (2018)
Outcomes of patients (pts) with hepatocellular carcinoma (HCC) treated with transarterial chemoembolization (TACE): Global OPTIMIS final analysis.
Markus Peck-Radosavljevic et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Wnt signalling modulates transcribed-ultraconserved regions in hepatobiliary cancers
Pietro Carotenuto et al.
GUT (2017)
Shp2 Promotes Liver Cancer Stem Cell Expansion by Augmenting β-Catenin Signaling and Predicts Chemotherapeutic Response of Patients
Daimin Xiang et al.
HEPATOLOGY (2017)
The evolving concept of liver cancer stem cells
Kouki Nio et al.
MOLECULAR CANCER (2017)
Chemoradiotherapy Resistance in Colorectal Cancer Cells is Mediated by Wnt/β-catenin Signaling
Georg Emons et al.
MOLECULAR CANCER RESEARCH (2017)
Molecular regulation and pharmacological targeting of the β-catenin destruction complex
Eline C. van Kappel et al.
BRITISH JOURNAL OF PHARMACOLOGY (2017)
The miR-491-3p/Sp3/ABCB1 axis attenuates multidrug resistance of hepatocellular carcinoma
Yang Zhao et al.
CANCER LETTERS (2017)
Ectopic overexpression of filamin C scaffolds MEK1/2 and ERK1/2 to promote the progression of human hepatocellular carcinoma
Baicai Yang et al.
CANCER LETTERS (2017)
The microtubule-associated protein PRC1 promotes early recurrence of hepatocellular carcinoma in association with the Wnt/β-catenin signalling pathway
Jianxiang Chen et al.
GUT (2016)
The adaptor protein Rai/ShcC promotes astrocyte-dependent inflammation during experimental autoimmune encephalomyelitis (vol 197, pg 480, 2016)
C. Ulivieri et al.
JOURNAL OF IMMUNOLOGY (2016)
Pygo2 activates MDR1 expression and mediates chemoresistance in breast cancer via the Wnt/β-catenin pathway
Z-M Zhang et al.
ONCOGENE (2016)
Targeting Wnt/β-catenin pathway in hepatocellular carcinoma treatment
Valery Vilchez et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2016)
Model of fibrolamellar hepatocellular carcinomas reveals striking enrichment in cancer stem cells
Tsunekazu Oikawa et al.
NATURE COMMUNICATIONS (2015)
Tumour suppressor TRIM33 targets nuclear β-catenin degradation
Jianfei Xue et al.
NATURE COMMUNICATIONS (2015)
Ubiquitin-like Protein FAT10 Promotes the Invasion and Metastasis of Hepatocellular Carcinoma by Modifying β-Catenin Degradation
Rongfa Yuan et al.
CANCER RESEARCH (2014)
Upregulated miR-130a increases drug resistance by regulating RUNX3 and Wnt signaling in cisplatin-treated HCC cell
Ning Xu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2012)
Teaching an old dogma new tricks: twenty years of Shc adaptor signalling
Melanie K. B. Wills et al.
BIOCHEMICAL JOURNAL (2012)
Wnt/β-catenin pathway regulates ABCB1 transcription in chronic myeloid leukemia
Stephany Correa et al.
BMC CANCER (2012)
The many faces and functions of β-catenin
Tomas Valenta et al.
EMBO JOURNAL (2012)
Rai is a New Regulator of Neural Progenitor Migration and Glioblastoma Invasion
Barbara Ortensi et al.
STEM CELLS (2012)
Interferon-α2b and transforming growth factor-β1 treatments on HCC cell lines: Are Wnt/β-catenin pathway and Smads signaling connected in hepatocellular carcinoma?
Maria Paula Ceballos et al.
BIOCHEMICAL PHARMACOLOGY (2011)
EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer
A. Singh et al.
ONCOGENE (2010)
The Wnt receptor FZD1 mediates chemoresistance in neuroblastoma through activation of the Wnt/β-catenin pathway
M. Flahaut et al.
ONCOGENE (2009)
Wnt signaling and skeletal development
Fei Liu et al.
CELLULAR SIGNALLING (2008)
Role of the MRP1/ABCC1 multidrug transporter protein in cancer
Marcia Munoz et al.
IUBMB LIFE (2007)
Shc3 affects human high-grade astrocytomas survival
L Magrassi et al.
ONCOGENE (2005)
Shc family expression in neuroblastoma:: High expression of shcC is associated with a poor prognosis in advanced neuroblastoma
E Terui et al.
CLINICAL CANCER RESEARCH (2005)
Domain-specific function of ShcC docking protein in neuroblastoma cells
I Miyake et al.
ONCOGENE (2005)
RAI(ShcC/N-Shc)-dependent recruitment of GAB1 to RET oncoproteins potentiates PI3-K signalling in thyroid tumors
V De Falco et al.
ONCOGENE (2005)
MYCN enhances P-gp/MDR1 gene expression in the human metastatic neuroblastoma IGR-N-91 model
E Blanc et al.
AMERICAN JOURNAL OF PATHOLOGY (2003)
Shc signaling in differentiating neural progenitor cells
L Conti et al.
NATURE NEUROSCIENCE (2001)
Share Paper
